Frozen Tissues Samples Market Overview and Growth by 2028

The frozen tissues samples market is projected to reach US$ 105,045.91 thousand by 2028 from US$ 44,399.07 thousand in 2021. The market is estimated to grow at a CAGR of 13.1% during 2021–2028.

Frozen tissue samples are preferred in analyses such as next-generation sequencing, western blotting for post-translational protein modifications, mass spectrometry, and quantitative real-time polymerase chain reaction. Frozen tissue samples are the gold standard for DNA and RNA sequencing, especially when the strands must be longer than 50 pairs. Frozen tissue samples are also useful in immunohistochemistry as the proteins are still preserved in their native state.   

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Frozen Tissues Samples Market: Strategic Insights

The global frozen tissues samples market growth is attributed to the rising application of frozen tissue samples in various research & therapeutic areas and the increasing use of frozen tissue samples due to the rising prevalence of cancer. However, the risk associated with preserving and maintaining frozen tissue samples is hampering the global frozen tissues samples market growth of the market to a certain extent.

Increasing Application of Frozen Tissue Samples due to Rising Prevalence of Cancer

According to the data published by Cancer Research UK in 2020, around 0.16 million people in the UK die each year due to cancer. Moreover, as per the Globocan report, in 2020, female breast cancer surpassed lung cancer as the most diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was 2-fold to 3-fold higher in transitioned than transitioning countries. However, female breast and cervical cancer deaths were considerably higher in transitioning than transitioned countries. Such a high prevalence of cancer is driving the need for frozen tissue samples for research and study. The increasing studies using frozen tumor tissue samples establish several diagnosis and treatment scopes for this chronic condition. Hence, the rising incidence of cancer worldwide is fueling the growth of the frozen tissue sample market. Moreover, in Canada, cancer is the leading cause of death among the population, and it is witnessed to be the second-leading cause after heart diseases in the US. According to the American Cancer Society, approximately 1.9 million new cancer cases are diagnosed, and 609,360 deaths in the US are estimated in 2022. Prostate cancers are the most commonly diagnosed cancers among males in North America; however, breast cancers remain leading in females. Additionally, lung cancer remains the most common cause of death among the population. It is estimated that the number of new cases of cancer incidence is 439.2 per 100,000 men and women per year. Therefore, the increasing prevalence of cancer among the population is leading to the growth of the frozen tissue samples market worldwide.

Product-Based Insights

The global frozen tissues samples market, based on product, is segmented into frozen normal tissues samples, frozen tumor tissues samples, and frozen diseased tissue samples. The frozen tissue tumor samples segment held the largest share of the market in 2021. Moreover, the same segment is anticipated to register the highest CAGR in the frozen tissues samples market during the forecast period of 2021 to 2028. The growth is mainly attributed due to increasing tumor cases globally.  

Application-Based Insights

Based on application, the global frozen tissues samples market is segmented into disease diagnosis and treatment, cancer and other diseases research, and morphological analysis. In 2021, the cancer and other diseases research segment accounted for the largest share of the global frozen tissues samples market. However, the diseases diagnosis and treatment segment is expected to grow at the fastest CAGR of 13.8% from 2021 to 2028.

End User-Based Insights

The global frozen tissues samples market, based on end user, is segmented into academic and research institutes, hospitals and clinics, diagnostic centers, and others. In 2021, the academic and research institutes segment held the largest share of the global frozen tissues samples market. However, the hospitals and clinics segment are expected to grow at the fastest CAGR of 13.9% from 2021 to 2028.

Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the frozen tissues samples market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally. The global frozen tissues samples market is anticipated to flourish with the development of new innovative products by market players.

The regional trends and factors influencing the Frozen Tissues Samples Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Frozen Tissues Samples Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Frozen Tissues Samples Market Report Scope

Frozen Tissues Samples Market Players Density: Understanding Its Impact on Business Dynamics

The Frozen Tissues Samples Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Company Profiles

• Audubon Bioscience Co
• REPROCELL Inc.
• Bay Biosciences LLC
• US Biolab Corporation, Inc
• AMS Biotechnology (Europe) Ltd.
• Geneticist, Inc
• ZenBio, Inc
• OriGene Technologies, Inc.
• BioChain Institute Inc
• ProteoGenex, Inc.